Rockefeller grants commercial license for the development of new HIV drugs
Thursday, February 27, 2020 - 09:40
in Mathematics & Economics
In a move that could help realize the promise of new strategies to control HIV, Rockefeller has entered a licensing agreement with a global pharmaceutical company to advance the development of investigational drugs based on broadly neutralizing antibodies discovered at the university. In a recent early-stage study, two of the licensed compounds were shown to […]